Additional Metadata
Keywords antipsoriasis agent, cyclosporin, efalizumab, etanercept, etretin, infliximab, methotrexate, new drug, psoralen
Persistent URL dx.doi.org/10.1159/000156598, hdl.handle.net/1765/14753
Citation
Nijsten, T.E.C., & Wakkee, M.. (2008). Psocare: Italy shows the way in postmarketing studies. Dermatology: international journal for clinical and investigative dermatology, 217(4), 362–364. doi:10.1159/000156598